Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.80 |
| ▸ | MAPT | P10636 | 1/20 | 0.80 |
| ▸ | CES2 | O00748 | 4/20 | 0.68 |
| ▸ | CES1 | P23141 | 4/20 | 0.68 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.65 |
| ▸ | PPARG | P37231 | 7/20 | 0.65 |
| ▸ | PPARD | Q03181 | 7/20 | 0.65 |
| ▸ | PPARA | Q07869 | 7/20 | 0.65 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.65 |
| ▸ | TSHR | P16473 | 5/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | TLR2 | O60603 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | FABP4 | P15090 | 2/20 | 0.65 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.65 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | ESR1 | P03372 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21044717 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044654 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044649 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044663 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23530128 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23530133 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23748450 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23530132 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044697 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044675 | 1.00 | KMT2A (0.80) | KMT2AMAPTCES2CES1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12516011-B2 | Method of producing higher alkanones, preferably 6-undecanone, and derivatives thereof | EVONIK OPERATIONS GMBH (DE) | 2026-01-06 | — | — | US | disclosed |
| EP-4153557-B1 | METHOD FOR PRODUCING HIGHER LINEAR FATTY ACIDS OR ESTERS | EVONIK OPERATIONS GMBH (DE) | 2024-07-03 | — | — | EP | disclosed |
| US-20240191264-A1 | METHOD FOR PRODUCING HIGHER LINEAR ALKANES | EVONIK OPERATIONS GMBH (DE) | 2024-06-13 | — | — | US | disclosed |
| EP-4314309-A2 | METHOD FOR PRODUCING HIGHER LINEAR ALKANES | Evonik Operations GmbH (DE) | 2024-02-07 | — | — | EP | disclosed |
| US-20230175025-A1 | METHOD FOR PRODUCING HIGHER LINEAR FATTY ACIDS OR ESTERS | EVONIK OPERATIONS GMBH (DE) | 2023-06-08 | — | — | US | disclosed |
| EP-4153557-A1 | METHOD FOR PRODUCING HIGHER LINEAR FATTY ACIDS OR ESTERS | Evonik Operations GmbH (DE) | 2023-03-29 | — | — | EP | disclosed |
| US-20210395179-A1 | METHOD OF PRODUCING HIGHER ALKANONES, PREFERABLY 6-UNDECANONE, AND DERIVATIVES THEREOF | EVONIK OPERATIONS GMBH (DE) | 2021-12-23 | — | — | US | disclosed |
| WO-2021233732-A1 | METHOD FOR PRODUCING HIGHER LINEAR FATTY ACIDS OR ESTERS | EVONIK OPERATIONS GMBH (DE) | 2021-11-25 | — | — | WO | disclosed |
| EP-3884061-A1 | METHOD OF PRODUCING HIGHER ALKANONES, PREFERABLY 6-UNDECANONE, AND DERIVATIVES THEREOF | Evonik Operations GmbH (DE) | 2021-09-29 | — | — | EP | disclosed |
| CN-113166785-A | Process for producing higher alkanones, preferably 6-undecanone, and derivatives thereof | 赢创运营有限公司 | 2021-07-23 | — | — | CN | disclosed |
| EP-3824886-A1 | NOVEL COMPOUNDS ISOLATED FROM CERVI PARVUM CORNU, AND PHARMACEUTICAL USES THEREOF | FNG Research Co., Ltd. (KR) | 2021-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230175025-A1 | METHOD FOR PRODUCING HIGHER LINEAR FATTY ACIDS OR ESTERS | FASN, FADS2, SCD | KMT2A 4196/4885MAPT 4025/4885CES2 355/4885 |
| US-20240191264-A1 | METHOD FOR PRODUCING HIGHER LINEAR ALKANES | ALKBH3, ALKBH1, AKR7A2 | KMT2A 3793/4885MAPT 3137/4885CES2 483/4885 |
| US-20210395179-A1 | METHOD OF PRODUCING HIGHER ALKANONES, PREFERABLY 6-UNDECANONE, AND DERIVATIVES THEREOF | ALK, ALKBH3, ULK3 | KMT2A 2233/4885MAPT 4068/4885CES2 1361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.